共 50 条
- [1] Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanerceptJournal of Translational Medicine, 9 (Suppl 2)Alistair I HenryHaiping GongAndrew M Nesbitt
- [3] Comparison of certolizumab pegol, etanercept, adalimumab and infliximab: Effect on lipopolysaccharide-induced cytokine production by human peripheral blood monocytesAMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S436 - S437Nesbitt, Andrew M.Fossati, GianlucaBrown, Derek T.
- [4] Investigation into the binding affinity of Certolizumab pegol to FcRn and functional consequences for FcRn-mediated transcytosis: comparison to Infliximab, Adalimumab and EtanerceptZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 107 - 107Nesbitt, A.Kevorkian, L.Baker, T.
- [5] Investigation into the binding affinity of certolizumab pegol to FcRn and functional consequences for FcRn-mediated transcytosis: comparison to infliximab, adalimumab and etanerceptJOURNAL OF CROHNS & COLITIS, 2014, 8 : S83 - S84Baker, T.Kevorkian, L.Nesbitt, A.
- [6] CERTOLIZUMAB PEGOL IN CROHN'S DISEASE REFRACTORY TO INFLIXIMAB AND ADALIMUMABATENCION FARMACEUTICA, 2009, 11 (03): : 178 - 180Jose, Morales Lara MaPenella Monica, MartinezGuzman Diana, LacruzVidal Vanessa, JorgeManeiro Vicente, SantaclaraSanchez Senador, Morandel Carmen, Mira Sirvent Ma
- [7] Antibodies to certolizumab pegol in patients with Crohn's disease do not cross-react with adalimumab, etanercept, or infliximabGASTROENTEROLOGY, 2007, 132 (04) : A556 - A556Vetterlein, Olivia M.Nesbitt, Andrew M.Stephens, Sue
- [8] Effect of certolizurnab pegol, etanercept, adalimumab and infliximab on cytokine productionINFLAMMATORY BOWEL DISEASES, 2007, 13 (05) : 656 - 656Brown, D.Nesbitt, A.Fossati, G.
- [10] Effects of certolizumab pegol, etanercept, adalimumab and infliximab on lipopolysaccharide-induced cytokine production by human peripheral blood monocytesGUT, 2007, 56 : A115 - A116Fossati, G.Brown, D. T.Nesbitt, A. M.